George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe-wide Patent Granted for G+ in Golf Balls

29 Mar 2021 07:00

RNS Number : 7227T
Directa Plus PLC
29 March 2021
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

29 March 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Europe-wide Patent Granted for G+ in Golf Balls

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an EU-wide patent covering the use of its G+® graphene in golf ball applications. The reference date for the patent is 23 December 2016.

 

The patent covers a family of formulations and compounds containing G+® graphene nanoplatelets for golf ball applications. Using these compounds at different loadings provides the basis for developing a new generation of high-performance golf balls aimed at both the professional and recreational markets. For professionals, G+® can be used to enhance the hard-core of golf balls to maximise shot distance, without losing lateral control. For amateurs, a different formulation of G+® can be used to increase distance while at the same time maximising control.

 

Following the grant of patent, Directa Plus will commence a selection process for a partner to commercialise the technology.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "The award of a Europe-wide patent for our G+® technology in golf balls is the first step towards addressing a very large global market. Our technology can deliver material benefits in terms of both distance and control to professional and recreational golfers. We look forward to working with our chosen partner to designing and launching a new generation of high-performance golf balls."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Pete Lynch

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASELFAAEFSEID
Date   Source Headline
28th Feb 20224:50 pmRNSExercise of Options
8th Feb 20225:20 pmRNSHolding(s) in Company
29th Dec 202111:11 amRNSResult of General Meeting & TVR
20th Dec 20217:00 amRNSGrant of EU Patent for Shoe Soles
10th Dec 20215:00 pmRNSPosting of Circular and Notice of General Meeting
10th Dec 202112:10 pmRNSResult of Placing and Subscription
9th Dec 20216:28 pmRNSClose of Bookbuild and Subscription
9th Dec 202112:30 pmRNSProposed Equity Raise
1st Dec 20217:00 amRNSCollaboration on Air and Water Filtration
29th Nov 20217:00 amRNSGrant Award for Industrial Filtration
24th Nov 20217:00 amRNSAward of Green Economy Mark
16th Nov 20217:00 amRNSDirectorate Change
11th Nov 20217:00 amRNSCompany Excellence Awards 2021 - Rising Star Award
1st Nov 20217:00 amRNSLaunch of High Performance Trail Running Shoes
14th Oct 20217:00 amRNSAdditional Italian Government Covid Recovery Loan
11th Oct 20217:00 amRNSInvestor Presentation
7th Oct 20217:00 amRNSReactivation of Decontamination Contract
29th Sep 20217:00 amRNSHalf-year Report
8th Sep 20217:00 amRNSMilan Design Week Showcases New G+ Coatings
9th Aug 20217:00 amRNSEU Grant Award
2nd Aug 20217:00 amRNSItalian Government Covid-19 Recovery Loans
28th Jul 20219:12 amRNSSignificant Tender Win
27th Jul 20217:00 amRNSSilver Medal Win in Shirt Printed by Directa
12th Jul 20217:00 amRNSPublication of peer reviewed scientific paper
23rd Jun 20215:19 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
17th Jun 20213:47 pmRNSAward of Options
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSNexTech Batteries Partnership Progresses
26th May 20215:20 pmRNSNotice of AGM
17th May 20217:00 amRNSFinal Results for the Year to 31 December 2020
5th May 20217:00 amRNSGrant of EU Production Process Patent
27th Apr 20217:00 amRNSImproved textile printing with graphene inks
19th Apr 20217:00 amRNSNew Safety Test
9th Apr 20217:00 amRNSAppointment of CFO
29th Mar 20217:00 amRNSEurope-wide Patent Granted for G+ in Golf Balls
18th Mar 20217:00 amRNSTrading Update
9th Mar 20217:00 amRNSSuccessful Absorption Evaluation Test
22nd Feb 20217:00 amRNSSupply and R&D Agreements with NexTech Batteries
10th Feb 202111:05 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSFlame retardant properties of G+ established
3rd Feb 20217:00 amRNSEU grant to enhance Covid resistant face-masks
29th Jan 20219:05 amRNSSecond Price Monitoring Extn
29th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20214:40 pmRNSSecond Price Monitoring Extn
28th Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSAddition to Decontamination and Recovery Contract
21st Jan 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.